RxDoctor Payments Data

Dharshan Lakshminarayan, MD

Hospitalist · Muskogee, OKNPI 1295198620

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $553 and has fallen 96.8% since, to $18 in 2022.

$678in general payments, 2019–2025

Across 14 payments — averaging $48.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$135
  • Takeda Pharmaceuticals U.S.A., Inc.$125
  • Boehringer Ingelheim$125
  • Merck$123
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$67
  • Johnson & Johnson$32
  • plus $73 from 4 others

What the payments were for

  • Food & beverage$678100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$678 in reported general payments places this provider in the 85th percentile of 234 hospitalist providers in Oklahoma.

See all hospitalist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$97,335
Medicare patients
313
Services billed
973

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$7,212
Nitroglycerin25$681
Doxycycline Hyclate43$231
Diltiazem 24hr Er (Cd)Diltiazem Hcl11$199
Hydralazine Hcl11$168
Cephalexin28$112
Metronidazole19$106
Metoprolol Tartrate13$105
Pantoprazole Sodium14$98
Levofloxacin24$79
Furosemide22$71
Prednisone30$69
Amlodipine Besylate13$51
Carvedilol13$45

Paid to pharmacies, not to this prescriber.

Other hospitalist in Muskogee

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →